DSGN icon

Design Therapeutics
DSGN

Overview Fund Activity

52 hedge funds and large institutions have $415M invested in Design Therapeutics in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 1 closing their positions.

Holders
52
Holders Change
+2
Holders Change %
+4%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
23
Reduced
11
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EC
1
EcoR1 Capital
California
$27.4M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$2.42M
3
TD Asset Management
3
TD Asset Management
Ontario, Canada
$965K
4
LGM
4
Logos Global Management
California
$40.7M
5
Goldman Sachs
5
Goldman Sachs
New York
$810K

Top Sellers

1
OCA
1
Octagon Capital Advisors
New York
$219K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$16M
3
BlackRock
3
BlackRock
New York
$19.3M
4
CAM
4
Cormorant Asset Management
Massachusetts
$78.8M
5
Northern Trust
5
Northern Trust
Illinois
$1.8M
Name Market Value Shares Shares
Change 		Shares
Change %
Osaic Holdings
51
Osaic Holdings
Arizona
$2K 96 – –
SOW
52
State of Wyoming
Wyoming
$1K 81 -40 -33%
PCM
53
Pinz Capital Management
New York
– – -4,338 Closed
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
1 2
3